HPV-based cervical-cancer screening in China

The Lancet Oncology

Volumn 11, Issue 12, 2010, Pages 1112-1113

  Arbyn, Marc ^a   Walker, Amy ^b   Meijer, Chris J L M ^c  

^a SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^b CITY HOSPITALS SUNDERLAND NHS FOUNDATION TRUST   (United Kingdom)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID;

ASSAY; CANCER GRADING; CANCER MORTALITY; CANCER SCREENING; CHINA; COLPOSCOPY; CYTOLOGY; DIAGNOSTIC ACCURACY; GEOGRAPHIC DISTRIBUTION; HUMAN; NOTE; PRIORITY JOURNAL; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; WART VIRUS; WOMEN'S HEALTH;

CHINA; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; PAPILLOMAVIRIDAE; UTERINE CERVICAL NEOPLASMS;

EID: 78649632994     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(10)70262-X     Document Type: Note

References (7)

1. Zhao F-H, Lin MJ, Chen F, et al. Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China. Lancet Oncol 2010, published online Nov 12. 10.1016/S1470-2045(10)70256-4.
2. Arbyn M, Sasieni P, Meijer CJ, Clavel C, Koliopoulos G, Dillner J Chapter 9: clinical applications of HPV testing: a summary of meta-analyses. Vaccine 2006, 24(suppl 3):S78-S89.
3. Arbyn M, Sankaranarayanan R, Muwonge R, et al. Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India. Int J Cancer 2008, 123:153-160.
4. Arbyn M, Ronco G, Cuzick J, Wentzensen N, Castle PE How to evaluate emerging technologies in cervical cancer screening?. Int J Cancer 2009, 125:2489-2496.
5. de Sanjose S, Diaz M, Castellsague X, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 2007, 7:453-459.
6. Ronco G, Giorgi-Rossi P, Carozzi F, et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol 2010, 11:249-257.
7. Arbyn M, Ronco G, Meijer CJLM, Naucler P Trials comparing cytology with HPV screening. Lancet Oncol 2009, 10:935-936.